Oscotec Inc.

Translating science into medicine
회원가입
PRESS
List of Articles
Date Site Media Pipeline
2016-08-23 INTERVIEW: Oscotec Lays Out Global Ambitions For RA, Cancer Drugs Scrip (Informa Pharma Intelligence) Oscotec
2019-06-25 Oscotec wins exception policy for continued R&D for new drugs KBR (; Korea Biomedical Review) Oscotec
2021-03-02 Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug CISION Oscotec
2021-03-02 Other news to note for March 2, 2021 BioWorld Oscotec
2023-09-14 Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease Biospace Oscotec
2024-02-23 Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease yahoo! finance Oscotec
2014-04-03 G-749, a novel FLT3 Kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia. PubMed SKI-G-801
2017-12-11 Oscotec shares rebound on launch of US clinical trial KBR (; Korea Biomedical Review) SKI-G-801
2018-11-23 Oscotec`s acute leukemia treatment wins orphan drug status from FDA KBR (; Korea Biomedical Review) SKI-G-801
2019-07-01 Abstract 2010 : SKI-G-801, an AXL kinase inhibitor, blocks metastasis and induces anti-tumor immune response in various syngeneic cancer models CANCER RESEARCH SKI-G-801
2019-11-04 AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications Molecular Cancer SKI-G-801
2016-01-19 Oscotec`s SYK inhibitor Program Gets Korea Drug Fund Money Scrip (Informa Pharma Intelligence) SYK-O-703
Board Pagination Prev 1 2 3 Next
/ 3
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
서버에 요청 중입니다. 잠시만 기다려 주십시오...